22-28725095-T-G

Variant names:

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6_Very_StrongBP7BS2_Supporting

The NM_007194.4(CHEK2):c.474A>C(p.Ala158Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000991 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A158A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)

Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

CHEK2
NM_007194.4 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.188

Publications

3 publications found

Variant links:

Genes affected

CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

CHEK2 Gene-Disease associations (from GenCC):

CHEK2-related cancer predisposition
Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
hereditary breast carcinoma
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
Li-Fraumeni syndrome 2
Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
acute myeloid leukemia
Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
hereditary nonpolyposis colon cancer
Inheritance: AD Classification: LIMITED Submitted by: ClinGen
familial ovarian cancer
Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

CHEK2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.46).

BP6

Variant 22-28725095-T-G is Benign according to our data. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28725095-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 183909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=0.188 with no splicing effect.

BS2

High AC in GnomAd4 at 7 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CHEK2	NM_007194.4 link	c.474A>C	p.Ala158Ala	synonymous_variant	Exon 4 of 15	ENST00000404276.6	NP_009125.1	O96017-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CHEK2	ENST00000404276.6 link	c.474A>C	p.Ala158Ala	synonymous_variant	Exon 4 of 15	1	NM_007194.4	ENSP00000385747.1		O96017-1

Frequencies

GnomAD3 genomes

AF:

0.0000460

AC:

AN:

152206

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.0000942

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000882

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000358

AC:

AN:

251416

AF XY:

0.0000589

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.0000289

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.0000462

Gnomad NFE exome

AF:

0.0000616

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.000105

AC:

153

AN:

1461818

Hom.:

Cov.:

AF XY:

0.0000990

AC XY:

AN XY:

727212

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33480

American (AMR)

AF:

0.0000224

AC:

AN:

44724

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26132

East Asian (EAS)

AF:

0.00

AC:

AN:

39678

South Asian (SAS)

AF:

0.00

AC:

AN:

86256

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53416

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5766

European-Non Finnish (NFE)

AF:

0.000136

AC:

151

AN:

1111974

Other (OTH)

AF:

0.0000166

AC:

AN:

60392

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.470

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000460

AC:

AN:

152206

Hom.:

Cov.:

AF XY:

0.0000134

AC XY:

AN XY:

74354

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41462

American (AMR)

AF:

0.00

AC:

AN:

15264

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5196

South Asian (SAS)

AF:

0.00

AC:

AN:

4832

European-Finnish (FIN)

AF:

0.0000942

AC:

AN:

10618

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.0000882

AC:

AN:

68042

Other (OTH)

AF:

0.00

AC:

AN:

2092

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.568

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.00

Hom.:

Bravo

AF:

0.0000416

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:9

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome

Benign:3

Dec 26, 2014

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Apr 27, 2016

Color Diagnostics, LLC DBA Color Health

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

May 26, 2021

Sema4, Sema4

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:curation

- -

not specified

Benign:2

Apr 26, 2019

Genetic Services Laboratory, University of Chicago

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Aug 28, 2019

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Benign:2

Nov 30, 2017

PreventionGenetics, part of Exact Sciences

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Mar 03, 2015

GeneDx

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Familial cancer of breast

Benign:2

Feb 03, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Oct 02, 2024

Myriad Genetics, Inc.

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.46

CADD

Benign

7.1

(source)

DANN

Benign

0.69

PhyloP100

0.19

Mutation Taster

=99/1

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over